Andrew Kruegel

Andrew_Kruegel

Kures, inc.

2015-2016

Affiliations

Columbia University

Technologies

Therapeutic

Indication

Basic Research

Central Nervous System Disorders

Pain Management

I am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression

Newsletter Signup

Corporate Supporters

Community Service Providers